The estimated Net Worth of Richard J. Mitrano is at least $18.5 Thousand dollars as of 18 August 2023. Mr. Mitrano owns over 464 units of Frequency Therapeutics Inc stock worth over $14,537 and over the last 5 years he sold FREQ stock worth over $3,939. In addition, he makes $0 as Vice President of Finance and Operations at Frequency Therapeutics Inc.
Richard has made over 20 trades of the Frequency Therapeutics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 464 units of FREQ stock worth $269 on 18 August 2023.
The largest trade he's ever made was exercising 7,500 units of Frequency Therapeutics Inc stock on 5 July 2022 worth over $2,250. On average, Richard trades about 875 units every 59 days since 2019. As of 18 August 2023 he still owns at least 48,457 units of Frequency Therapeutics Inc stock.
You can see the complete history of Mr. Mitrano stock trades at the bottom of the page.
Richard Mitrano serves as Vice President of Finance and Operations of the Company. From 2012 to 2015, Mr. Mitrano served as the Director of Finance and Operations of Semprus, where he oversaw all accounting and finance operations and provided strategic direction and oversight. Prior to Semprus, Mr. Mitrano was a contract Accounting Manager for Predictive Biosciences, Inc., or Predictive, a diagnostics company, from 2010 to 2012. Prior to Predictive, from 2008 to 2010, Mr. Mitrano served as Corporate Controller of Pioneer Behavioral Health, a company providing behavioral health services. Mr. Mitrano holds a B.A. in Accounting from Bentley University.
Richard Mitrano is 49, he's been the Vice President of Finance and Operations of Frequency Therapeutics Inc since 2016. There are 12 older and 4 younger executives at Frequency Therapeutics Inc. The oldest executive at Frequency Therapeutics Inc is Timothy Barberich, 72, who is the Independent Director.
Richard's mailing address filed with the SEC is C/O FREQUENCY THERAPEUTICS, INC.,, 75 HAYDEN AVE, SUITE 300, LEXINGTON, MA, 02421.
Over the last 5 years, insiders at Frequency Therapeutics Inc have traded over $11,017,122 worth of Frequency Therapeutics Inc stock and bought 369,233 units worth $5,339,982 . The most active insiders traders include Joel S Marcus, Robert Langer, and Marc A Cohen. On average, Frequency Therapeutics Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,858. The most recent stock trade was executed by Richard J. Mitrano on 18 August 2023, trading 464 units of FREQ stock currently worth $269.
frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the complexity of genetic engineering. our lead program re-creates sensory cells in the inner ear to treat chronic noise induced hearing loss, which affects over 30 million people in the u.s. alone.
Frequency Therapeutics Inc executives and other stock owners filed with the SEC include: